OxyElite returns with a new panel behind an old name
A famous stimulant brand is back for Europe with a fully disclosed panel. The disclosure is genuinely good; the case published for three of the inclusions is not.
A dormant brand returning to shelves is not, on its own, a story. What makes this one worth a review is that the name is famous and the formula behind it is new, so a buyer searching for the name finds a panel the trade report itself describes as not the one that built the brand’s reputation.
One thing to establish first. This desk is not going to recount the brand’s earlier history: we could not open a primary record of it, and we do not write history from memory. What the trade report says about the past — that this is not the DMAA-era formula, though the packaging and colour scheme carry over some of the original identity — is the whole of what we will assert.
The published panel
Start with what is good. Every active is named with a number against it, and there is no proprietary blend hiding six ingredients behind one weight — in a stimulant product, the usual failure mode. The caffeine is stated as caffeine rather than smuggled in as “green coffee complex”, and the directed frequency is stated too, so the daily total is a multiplication anybody can do. A low bar, cleanly cleared.
The caffeine arithmetic
160 mg per serving, twice daily, is 320 mg of caffeine a day from this product alone. That is the single number a buyer should carry around.
Tolerance varies enormously, and no label — and no reviewer — can tell any individual where they sit. The problem is not the dose on the panel; it is that the panel is the only thing accounting for it. A second serving taken later than intended, a coffee, and a pre-workout with its own stimulant load are three separate decisions, and no label involved knows about the other two. Stacking is how people reach totals they did not choose. Do not exceed what the label directs, and if caffeine sensitivity, blood pressure, heart rhythm or sleep are things a doctor already discusses with you, this is a product to raise with them rather than settle from a product page.
Three inclusions the launch report doses but does not justify
Dandelion extract at 400 mg is the largest amount here and the one we would most want a rationale for. Dandelion carries a long association in this category with fluid balance rather than body composition, and the report publishes a dose without publishing anything behind it. A short-term shift in body water is not a change in body fat, and a product producing the former while sold on the latter is trading on a number the buyer will misread on a scale.
Cocoabuterol and ProGBB, at 50 mg and 30 mg, are branded ingredients — proprietary preparations sold to formulators. That is not inherently a problem; some of the best-documented things here are branded. But the case for a branded ingredient lives in the trials its supplier has published at the dose used, and the report announcing this formula gives us a dose and a trademark without pointing at one. Until a citation accompanies them they are inclusions rather than evidence, and the burden sits with the brand. Olive extract at 100 mg is in the same position, on less of the formula. Capsimax and BioPerine are branded preparations too, though both are long-established and unexotic — and the BioPerine amount goes unstated.
The pattern is familiar: full disclosure of what is in the bottle, none at all of why. Those are different transparencies, and the first is much the easier to supply.
None of this has been evaluated by the Food and Drug Administration, and no capsule in this category is intended to diagnose, treat, cure or prevent any disease or to stand in for medical care. We will not tell you what this product will do for you; that is not a number anybody can honestly give.
What the name is doing
The name carries recognition a new brand would spend years buying, and it arrives attached to a formula that must be judged on its own panel — the same gap between a reputation and a label that this site keeps pointing at. To the brand’s credit, the relaunch was reported with the panel attached rather than teased, and the break from the original stated openly.
Pros and cons
Verdict
This is a defensibly built product with an undefended rationale. Judged as a label it does what we spend most of our time asking labels to do: names its actives, states its caffeine, publishes its directions. Judged as evidence it is a list. Buy it, if you buy it, knowing the daily caffeine figure and that caffeine is the ingredient here with the clearest published basis — and knowing that the name on the front is telling you about a product you are not being sold.